Lihua Zhang
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
AS-IV inhibits the progression of ovarian cancer by targeting the circ_0124787/miR-6875-3p/IL-1β axis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 29, 2025
Development of the model for predicting the efficacy of bevacizumab and prognosis in ovarian cancer using deep learning-based pathomics signatures.
Journal: Chinese medical journal
Published: March 26, 2025
SMURF2 Inhibits Autophagy and Growth in Ovarian Cancer by Regulating the RACK1/AKT/mTOR Pathway.
Journal: American journal of reproductive immunology (New York, N.Y. : 1989)
Published: February 06, 2025
IGF2BP3-mediated regulation of GLS and GLUD1 gene expression promotes treg-induced immune escape in human cervical cancer.
Journal: American journal of cancer research
Published: July 23, 2023
CircATRNL1 and circZNF608 Inhibit Ovarian Cancer by Sequestering miR-152-5p and Encoding Protein.
Journal: Frontiers in genetics
Published: September 27, 2021
Mutation Landscape of Homologous Recombination Repair Genes in Epithelial Ovarian Cancer in China and Its Relationship With Clinicopathlological Characteristics.
Journal: Frontiers in oncology
Published: June 25, 2021
Novel gene signatures for prognosis prediction in ovarian cancer.
Journal: Journal of cellular and molecular medicine
Published: February 17, 2020
Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer.
Journal: Medical oncology (Northwood, London, England)
Published: November 15, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026